An antigen or protein marker on cells that may indicate ankylosing spondylitis.
| Medical Glossary: HLA-B27 |
| 5min Related Video: HLA-B27 |
| Wikipedia: HLA-B27 |
![]() |
||
| B*2705-β2MG with bound peptide 2bst | ||
|
major histocompatibility complex (human), class I, B27
|
||
| Alleles | B*2701, 2702, 2703, . . . |
|
| Structure (See HLA-B) | Available 3D structures |
|
| EBI-HLA | B*2701 | |
| B*2702 | ||
| B*2703 | ||
| B*2704 | ||
| B*2705 | 2bsr, 2bss, 2bst, 2a83, 1w0v, 1uxs, 1ogt, 1hsa, 1jgd, 1jge |
|
| B*2706 | ||
| B*2709 | 1w0w, 1uxw, 1of2, 1k5n |
|
Human Leukocyte Antigen B*27 (subtypes B*2701-2724) is a class I surface antigen encoded by the B locus in the major histocompatibility complex (MHC) on chromosome 6 and presents microbial antigens to T-cells. HLA-B27 is strongly associated with a certain set of autoimmune diseases referred to as the "seronegative spondyloarthropathies". In the general population, about 8% Caucasian, 4% African, 2-9% Chinese, and 0.1-0.5% Japanese have the HLA-B27 antigen. In Northern Scandinavia (Lapland), 24% of people are HLA-B27 positive while 1.8% have associated ankylosing spondylitis (AS).
Contents |
| B*27 | B27 | Sample | |
| allele | % | % | size (N) |
| 2701 | 100 | 9 | |
| 2702 | 67 | 417 | |
| 2703 | 88 | 26 | |
| 2704 | 97 | 34 | |
| 2705 | 97 | 1197 | |
| 2706 | 97 | 29 |
| freq | ||
| ref. | Population | (%) |
| [2] | Bulgaria | 4.6 |
| Bulgaria Gipsy | 4.5 | |
| Brazil Belo Horizonte | 2.6 | |
| Romanian | 2.2 | |
| Czech Republic | 1.9 | |
| Croatia | 1.7 | |
| Finland | 1.7 | |
| Spain E. Andalusia Gipsy | 1.5 | |
| Tunisia Tunis | 1.1 | |
| [2] | HLA B*2703 frequencies | |
| Romanian | 3.2 | |
| Kenya Nandi | 2.5 | |
| CAR Mbenzele Pygmy | 2.0 | |
| Sudanese | 1.8 | |
| Alaska Yupik Natives | 1.8 | |
| Senegal Niokholo Mandenka | 1.6 | |
| Guinea Bissau | 1.5 | |
| Kenya | 1.4 | |
| Georgia Svaneti Svans | 1.3 | |
| India North Delhi | 1.1 | |
| Ivory Coast Akan Adiopodoume | 1.1 | |
| [2] | HLA B*2704 frequencies | |
| PNG Karimui Plateau | 22.5 | |
| Taiwan Pazeh | 10.9 | |
| PNG West Schrader Ranges | 9.1 | |
| Tibet (China) Tibetans | 7.0 | |
| Taiwan Siraya | 6.9 | |
| Bulgaria Gipsy | 4.5 | |
| New Caledonia | 3.9 | |
| China Guangzhou | 2.5 | |
| India Mumbai Marathas | 2.5 | |
| Singapore Thai | 2.5 | |
| Thailand | 2.0 | |
| China Inner Mongolia | 1.5 | |
| China South Han | 1.2 | |
| Philippines Ivatan | 1.0 | |
| Taiwan Ami | 1.0 |
The relationship between HLA-B27 and many diseases has not yet been fully elucidated. Though it is associated with a wide range of pathology, it does not appear to be the sole mediator in development of disease.[citation needed] For example, while 90% of people with ankylosing spondylitis (AS) are HLA-B27 positive, only a fraction of people with HLA-B27 ever develop AS. This raises two important questions: why don't all HLA-B27 positive people develop AS, and why do some people who are HLA-B27 negative develop it?[citation needed] The literature is inconclusive, though several theories have been suggested. Research however has been discontinued in many countries due to lack of funding.[citation needed]
In Croatian children, two B27 alleles were found associated with disease, B*2702, B*2705.[3] The study showed also B*0702 in coorperation with B*27, the HLA-B*07/B*27 combination with D6S273-134 genomic marker allele and was found not to be the result of linkage disequilibrium. B*2795 was found to be dominant allele associated.
| [2] | USA Alaska Yupik | 11.5 |
| Native American | 8.6 | |
| Arizona Pima ind. | 7.9 | |
| Belgium | 7.1 | |
| Mexico Tarahumara | 6.8 | |
| Finland | 6.1 | |
| Ireland South | 4.2 | |
| India Tamil Nadu Nadar | 4.1 | |
| India North Hindus | 3.8 | |
| Croatia | 3.7 | |
| Portugal North | 3.3 | |
| Mexico Guadalajara Mestizos | 2.9 | |
| Czech Republic | 2.8 | |
| Azores Terceira Island | 2.7 | |
| Azores Santa Maria & Sao Miguel | 2.6 | |
| South Korea pop 3 | 2.5 | |
| Cape Verde Northwestern Islands | 2.4 | |
| France South East | 2.3 | |
| Morocco Nador Metalsa Class I | 2.1 | |
| Portugal South | 2.0 | |
| Spain Eastern Andalusia Gipsy | 2.0 | |
| Italy North Pavia | 1.9 | |
| Azores Central Islands | 1.8 | |
| Bulgaria | 1.8 | |
| Israel Jews | 1.8 | |
| Georgia Tibilisi Kurds | 1.7 | |
| Brazil Belo Horizonte | 1.6 | |
| Cape Verde Southeastern Islands | 1.6 | |
| India New Delhi | 1.5 | |
| Mexico Sonora Seri | 1.5 |
In addition to its connection with ankylosing spondylitis, HLA-B27 is implicated in reactive arthritis, certain eye disorders such as acute anterior uveitis and iritis, psoriatic arthritis and ulcerative colitis. The common association with HLA-B27 leads to increased association of these disorders with each other.[4]
| This article includes a list of references or external links, but its sources remain unclear because it has insufficient inline citations. Please help to improve this article by introducing more precise citations where appropriate. (April 2009) |
|
|||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
| Ankylosing Spondylitis: Diagnosis | |
| Ankylosing Spondylitis: Causes and symptoms | |
| Reiter's Syndrome: Causes and symptoms |
| What is the value of a new in box Browning B27 shotgun? Read answer... | |
| Why is hla called an antigen? Read answer... | |
| What was the procedure employed in HLA testing? Read answer... |
| What is the role of b27 in neuronal cell cultures? | |
| What is Anti-HLA? | |
| What is the importance of HLA? |
Copyrights:
![]() | Medical Glossary. © 2006 through a partnership of Answers Corporation. All rights reserved. Read more | |
![]() | Wikipedia. This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "HLA-B27". Read more |
Mentioned in